Deutsche Bank Aktiengesellschaft Raises HealthEquity (NASDAQ:HQY) Price Target to $115.00

HealthEquity (NASDAQ:HQY - Free Report) had its price target hoisted by Deutsche Bank Aktiengesellschaft from $98.00 to $115.00 in a report published on Thursday,Benzinga reports. The brokerage currently has a buy rating on the stock.

Several other research firms have also commented on HQY. Wells Fargo & Company raised their price target on HealthEquity from $110.00 to $125.00 and gave the stock an "overweight" rating in a research report on Wednesday, February 26th. KeyCorp decreased their target price on HealthEquity from $110.00 to $100.00 and set an "overweight" rating for the company in a report on Wednesday, April 16th. Bank of America lifted their target price on HealthEquity from $110.00 to $125.00 and gave the company a "buy" rating in a report on Wednesday. JMP Securities lifted their target price on HealthEquity from $110.00 to $117.00 and gave the company a "market outperform" rating in a report on Wednesday. Finally, Royal Bank of Canada raised their price target on HealthEquity from $112.00 to $117.00 and gave the company an "outperform" rating in a research note on Wednesday. One research analyst has rated the stock with a hold rating, nine have issued a buy rating and one has assigned a strong buy rating to the company. According to MarketBeat, the stock has an average rating of "Buy" and an average price target of $118.09.

HealthEquity Price Performance

Shares of HealthEquity stock traded down $1.15 during mid-day trading on Thursday, reaching $111.55. 1,893,274 shares of the stock traded hands, compared to its average volume of 828,878. The business has a 50-day moving average of $91.48 and a 200 day moving average of $97.80. HealthEquity has a fifty-two week low of $65.01 and a fifty-two week high of $116.65. The stock has a market capitalization of $9.65 billion, a PE ratio of 102.34, a PEG ratio of 1.60 and a beta of 0.45. The company has a quick ratio of 3.20, a current ratio of 3.20 and a debt-to-equity ratio of 0.51.

HealthEquity (NASDAQ:HQY - Get Free Report) last announced its earnings results on Tuesday, June 3rd. The company reported $0.97 EPS for the quarter, beating analysts' consensus estimates of $0.81 by $0.16. HealthEquity had a return on equity of 9.70% and a net margin of 8.41%. The business had revenue of $330.80 million during the quarter, compared to analysts' expectations of $322.25 million. During the same quarter in the prior year, the firm earned $0.80 earnings per share. On average, analysts predict that HealthEquity will post 2.32 EPS for the current year.

Insider Buying and Selling at HealthEquity

In related news, Director Robert W. Selander sold 5,750 shares of the company's stock in a transaction that occurred on Wednesday, April 9th. The stock was sold at an average price of $77.65, for a total value of $446,487.50. Following the sale, the director now owns 84,969 shares in the company, valued at $6,597,842.85. This represents a 6.34% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, EVP Michael Henry Fiore sold 8,881 shares of the stock in a transaction on Friday, April 4th. The stock was sold at an average price of $78.26, for a total value of $695,027.06. Following the transaction, the executive vice president now directly owns 56,655 shares in the company, valued at approximately $4,433,820.30. This represents a 13.55% decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On HealthEquity

A number of hedge funds and other institutional investors have recently bought and sold shares of HQY. Arcadia Investment Management Corp MI acquired a new position in shares of HealthEquity during the fourth quarter worth approximately $26,000. Versant Capital Management Inc bought a new position in shares of HealthEquity in the first quarter valued at $28,000. WPG Advisers LLC bought a new position in shares of HealthEquity in the first quarter valued at $28,000. Transce3nd LLC bought a new position in shares of HealthEquity in the fourth quarter valued at $29,000. Finally, Smartleaf Asset Management LLC increased its holdings in shares of HealthEquity by 34.3% in the fourth quarter. Smartleaf Asset Management LLC now owns 384 shares of the company's stock valued at $37,000 after buying an additional 98 shares in the last quarter. 99.55% of the stock is currently owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.